We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
- Authors
Fisher, B; Dignam, J; Wolmark, N; DeCillis, A; Emir, B; Wickerham, D L; Bryant, J; Dimitrov, N V; Abramson, N; Atkins, J N; Shibata, H; Deschenes, L; Margolese, R G
- Abstract
The B-20 study of the National Surgical Adjuvant Breast and Bowel Project (NSABP) was conducted to determine whether chemotherapy plus tamoxifen would be of greater benefit than tamoxifen alone in the treatment of patients with axillary lymph node-negative, estrogen receptor-positive breast cancer.
- Publication
Journal of the National Cancer Institute, 1997, Vol 89, Issue 22, p1673
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/89.22.1673